Eighty percent of the AIA-positive patients on TOUJEO with antibody test at baseline remained AIA positive at month 6
We break down how each ingredient works, when to use them, and why combining both may be your fastest route to an even, glowing complexion
Research shows GLP-1 receptor agonists effectively reduce visceral fat, though whether this reduction is preferential compared to subcutaneous fat continues to be investigated
If weight management is the reason you are considering a GLP-1, it may help to ask your provider: Is this medically appropriate for me right now
Frame it in terms of plateaued progress, need for additional appetite support, desire for the metabolic benefits the combination provides, or interest in accelerating fat loss while preserving muscle
NICE guidance emphasises the importance of monitoring nutritional status during weight management interventions